Unicycive Therapeutics, Inc.

NASDAQ:UNCY

0.7692 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -36.729-30.544-18.058-10.017-2.264-2.165-1.12
Depreciation & Amortization 0.4280.2840.1610.013000
Deferred Income Tax 0000.127000
Stock Based Compensation 2.351.7671.0470.9660.2320.0240
Change In Working Capital -0.427-0.0931.178-0.105-0.1660.3050.006
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0.791.2761.2671.241-0.0680.3080.031
Other Working Capital -1.217-1.369-0.089-1.346-0.098-0.003-0.025
Other Non Cash Items 5.80310.3030.0213.2490.7390.660.308
Operating Cash Flow -28.575-18.283-15.651-5.767-1.459-1.176-0.775
Investing Activities:
Investments In Property Plant And Equipment -0.072-0.012-0.002-0.029000
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow -0.072-0.012-0.002-0.029000
Financing Activities:
Debt Repayment 00001.4200
Common Stock Issued 0.68328.0370.01122.2710.1411.1660.25
Common Stock Repurchased 0000000
Dividends Paid -1.095000000
Other Financing Activities 45.527.541-0.48222.375-0.1171.1660.8
Financing Cash Flow 45.08827.541-0.47122.3751.4441.1660.8
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 16.4419.246-16.12416.579-0.015-0.010.025
Cash At End Of Period 26.1429.7010.45516.57900.0150.025